Sign In
Buy QGEN
$41.40
-0.0500 (-0.121%)
At Close: Jul 31, 2026
Bragar Eagel and Squire, P. C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Qiagen (QGEN) To Contact Him Directly To Discuss Their Options If you purchased or acquired
QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V.
10:47am, Friday, 15'th May 2026
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Qiagen (QGEN) To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN
10:20pm, Thursday, 14'th May 2026
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Qiagen N.V. ("Qiagen" or the "Company") (NYSE: QGEN).
QGEN SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
07:00pm, Thursday, 14'th May 2026
NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Qiagen N.V. (“Qiagen” or the “Company”) (NYSE:QGEN) investor
Levi & Korsinsky Announces Investigation of Securities Claims Against Qiagen N.V. (QGEN)
09:00am, Thursday, 14'th May 2026
Qiagen's CEO and CFO signed SEC filings and personally delivered the guidance that was slashed within weeks -- investors who lost money may have legal claims against the individuals who controlled the
QGEN Investor Alert: Levi & Korsinsky Investigates Qiagen (QGEN) for Potential Securities Fraud
09:00am, Wednesday, 13'th May 2026
Qiagen's forward-looking non-GAAP guidance lacked required GAAP reconciliations under SEC Regulation S-K Item 10(e) -- institutional investors who relied on these figures for portfolio allocation deci
Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
12:20am, Wednesday, 13'th May 2026
Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
QIAGEN N.V. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
08:00pm, Tuesday, 12'th May 2026
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Qiagen N.V. (“Qiagen” or the “Company”) (NYSE:QGEN). The investigation concerns whether
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced proposals for its 2026 Annual General Meeting, including plans to appoint co-f
Deciphering Qiagen (QGEN) International Revenue Trends
10:16am, Monday, 11'th May 2026
Examine Qiagen's (QGEN) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Lost Money on Qiagen N.V. (QGEN)? Contact Levi & Korsinsky to Protect Your Rights
12:08am, Monday, 11'th May 2026
New York, New York--(Newsfile Corp. - May 11, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. (NYSE: QGEN) ("Qiagen N.V.
Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing Transcript
QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations
09:00am, Thursday, 07'th May 2026
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Qiagen (NASDAQ: QGEN) investors lost approximately 10% of their share value after the company slashed FY 2026 sales-growth guidance from "at least 5% CER" to
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to advance its QuantiFERON latent tuberculosis (TB) test with a new
Qiagen (QGEN) Q1 Earnings and Revenues Lag Estimates
10:51pm, Wednesday, 06'th May 2026
Qiagen (QGEN) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.58 per share a year ago.
